tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Revenue

Compare
629 Followers

Sonnet BioTherapeutics Holdings Revenue

Sonnet BioTherapeutics Holdings had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 1.00M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Sonnet BioTherapeutics Holdings had annual revenue of 18.63K with -87.40% growth.
Revenue (ttm)
1.00M
Revenue Growth
1689.52%
P/S Ratio
1216.00
Revenue/Employee
$1,433
Employees
13
Market Cap
$22.65M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.63K-129.18K+12.60%
Dec 31, 2023
147.81K-202.14K+42.24%
Dec 31, 2022
349.94K-133.68K+72.36%
Dec 31, 2021
483.63K-48,362,600.00%
Dec 31, 2020
-40.61M
Dec 31, 2019
40.61M9.88M+132.15%
Dec 31, 2018
30.73M-10.70M+74.18%
Dec 31, 2017
41.43M-269.14K+99.35%
Dec 31, 2016
41.70M